Belgian DFI doubling in size, aims to stay focused on SMEs

BIO CEO Luuk Zonneveld. Photo by: Rikolto / CC BY-NC-ND

WASHINGTON — Belgium’s development finance institution, the Belgian Investment Company for Developing Countries, or BIO, is in the process of doubling its investments, in part as a response to the growing role of private capital in addressing development challenges.

The agency will soon have a total of $1 billion in investments, and as it grows in size, BIO is trying to maintain its focus on supporting small- and medium-sized enterprises in least-developed countries, BIO CEO Luuk Zonneveld, told Devex in an interview.

Should your team be reading this?
Contact us about a group subscription to Pro.

About the author

  • Saldiner adva

    Adva Saldinger

    Adva Saldinger is an Associate Editor at Devex, where she covers the intersection of business and international development, as well as U.S. foreign aid policy. From partnerships to trade and social entrepreneurship to impact investing, Adva explores the role the private sector and private capital play in development. A journalist with more than 10 years of experience, she has worked at several newspapers in the U.S. and lived in both Ghana and South Africa.